Merit Medical Systems EPS - Earnings per Share 2010-2023 | MMSI

Merit Medical Systems eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Merit Medical Systems Annual EPS
2023 $1.62
2022 $1.29
2021 $0.84
2020 $-0.18
2019 $0.10
2018 $0.78
2017 $0.55
2016 $0.45
2015 $0.53
2014 $0.53
2013 $0.39
2012 $0.46
2011 $0.58
2010 $0.35
2009 $0.63
Merit Medical Systems Quarterly EPS
2023-12-31 $0.47
2023-09-30 $0.44
2023-06-30 $0.35
2023-03-31 $0.36
2022-12-31 $0.57
2022-09-30 $0.27
2022-06-30 $0.27
2022-03-31 $0.18
2021-12-31 $0.35
2021-09-30 $0.21
2021-06-30 $0.09
2021-03-31 $0.19
2020-12-31 $0.27
2020-09-30 $-0.05
2020-06-30 $-0.34
2020-03-31 $-0.06
2019-12-31 $-0.07
2019-09-30 $-0.06
2019-06-30 $0.12
2019-03-31 $0.11
2018-12-31 $0.17
2018-09-30 $0.30
2018-06-30 $0.21
2018-03-31 $0.10
2017-12-31 $0.11
2017-09-30 $-0.07
2017-06-30 $0.19
2017-03-31 $0.32
2016-12-31 $0.17
2016-09-30 $0.02
2016-06-30 $0.16
2016-03-31 $0.10
2015-12-31 $0.13
2015-09-30 $0.11
2015-06-30 $0.17
2015-03-31 $0.12
2014-12-31 $0.19
2014-09-30 $0.18
2014-06-30 $0.09
2014-03-31 $0.07
2013-12-31 $0.15
2013-09-30 $0.13
2013-06-30 $0.09
2013-03-31 $0.02
2012-12-31 $0.01
2012-09-30 $0.17
2012-06-30 $0.14
2012-03-31 $0.14
2011-12-31 $0.11
2011-09-30 $0.11
2011-06-30 $0.18
2011-03-31 $0.18
2010-12-31 $0.12
2010-09-30 $-0.06
2010-06-30 $0.16
2010-03-31 $0.13
2009-12-31 $0.14
2009-09-30 $0.17
2009-06-30 $0.17
2009-03-31 $0.15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.122B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.176B 18.25
Becton Dickinson (BDX) United States $67.358B 19.56
West Pharmaceutical Services (WST) United States $27.623B 46.70
Cardinal Health (CAH) United States $25.783B 15.50
Align Technology (ALGN) United States $22.677B 45.73
Cooper (COO) United States $17.970B 27.19
Labcorp (LH) United States $16.779B 14.33
Henry Schein (HSIC) United States $8.990B 15.55
DENTSPLY SIRONA (XRAY) United States $6.312B 16.63
STAAR Surgical (STAA) United States $2.285B 71.95
Patterson (PDCO) United States $2.282B 10.93
CONMED (CNMD) United States $2.189B 20.60
Atrion (ATRI) United States $0.679B 34.97
Lifevantage (LFVN) United States $0.086B 13.88
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00